Journal of Cardiovascular Development and Disease (Nov 2023)

Efficacy and Safety of Isoprenaline during Unstable Third-Degree Atrioventricular Block

  • Manuel De Lazzari,
  • Nicolò Martini,
  • Federico Migliore,
  • Filippo Donato,
  • Luciano Babuin,
  • Giuseppe Tarantini,
  • Martina Perazzolo Marra,
  • Luisa Cacciavillani,
  • Emanuele Bertaglia,
  • Andrea Bortoluzzi,
  • Vito Cianci,
  • Domenico Corrado,
  • Sabino Iliceto,
  • Alessandro Zorzi

DOI
https://doi.org/10.3390/jcdd10120475
Journal volume & issue
Vol. 10, no. 12
p. 475

Abstract

Read online

Unstable and symptomatic complete atrioventricular block represents a potentially fatal condition that requires prompt therapy while waiting for definitive pacemaker implantation. Although transcutaneous pacing is included in acute management, it could be a difficult approach due to its painfulness and the occasional failure of mechanical capture. Drug therapy is a feasible choice, and current guidelines encompass the use of atropine, dopamine, or epinephrine. Isoprenaline has never been investigated in this setting, and no specific indication of its use has been provided despite its potentially more favorable pharmacological profile. The study population included a consecutive series of patients who presented to the emergency department because of unstable third-degree atrioventricular block and were treated with either isoprenaline or dopamine infusion while waiting for definitive pacemaker implantation. Asymptomatic patients or those with reversible causes of complete atrioventricular block were excluded. The clinical response to the drug was deemed poor if, despite achieving a full drug dose, patients remained symptomatic and/or with hemodynamic instability, ventricular rate and rhythm did not improve or worsened, including if ventricular arrhythmias or asystolic pauses and/or irrepressible nausea/vomiting occurred. Isoprenaline infusion has proved to be safe and tolerated with no arrhythmia induction or hypotensive issues. Isoprenaline has also proven to be more satisfactory in achieving an effective clinical response in 84% of patients rather than dopamine (31%, p < 0.001), reducing the need for temporary artificial pacing. Our data point out the efficacy and safety of isoprenaline infusion and its greater tolerability over dopamine in the acute management of unstable third-degree AV block while waiting for definitive pacemaker implantation.

Keywords